調査レポート | • レポートコード：QYR2104Z3405 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、白血病治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（グリベック、サパシタビン、GA101、バサロキシン、トセドサット、レブリミド、ボスチニブ）、用途別市場規模（病院、研究所、診断センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・白血病治療薬の市場動向 ・企業の競争状況、市場シェア ・白血病治療薬の種類別市場規模（グリベック、サパシタビン、GA101、バサロキシン、トセドサット、レブリミド、ボスチニブ） ・白血病治療薬の用途別市場規模（病院、研究所、診断センター、その他） ・白血病治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・白血病治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・白血病治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・白血病治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・白血病治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GSK、Pfizer、Novartis AG、Roche、Celgene、Biogen、Genzyme Corporation、Eisai C.、Bristol Myers Squibb Company (BMS)） ・結論 |
Leukemia Treatment Drugs is used to cure Leukemia.
Increasing geriatric population base and high unmet needs regarding early diagnosis and treatment of leukemia are the key factors driving the leukemia therapeutics market.
Market Analysis and Insights: Global Leukemia Treatment Drugs Market
The global Leukemia Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Leukemia Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Leukemia Treatment Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Leukemia Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Leukemia Treatment Drugs market.
Global Leukemia Treatment Drugs Scope and Market Size
Leukemia Treatment Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Leukemia Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Gleevec
Sapacitabine
GA101
Vasaroxine
Tosedosat
Revlimid
Bosutinib
Segment by Application
Hospitals
Research Institutes
Diagnostic Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GSK
Pfizer
Novartis AG
Roche
Celgene
Biogen
Genzyme Corporation
Eisai C.
Bristol Myers Squibb Company (BMS)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leukemia Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gleevec
1.2.3 Sapacitabine
1.2.4 GA101
1.2.5 Vasaroxine
1.2.6 Tosedosat
1.2.7 Revlimid
1.2.8 Bosutinib
1.3 Market by Application
1.3.1 Global Leukemia Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Research Institutes
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Leukemia Treatment Drugs Market Perspective (2016-2027)
2.2 Leukemia Treatment Drugs Growth Trends by Regions
2.2.1 Leukemia Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Leukemia Treatment Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Leukemia Treatment Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Leukemia Treatment Drugs Industry Dynamic
2.3.1 Leukemia Treatment Drugs Market Trends
2.3.2 Leukemia Treatment Drugs Market Drivers
2.3.3 Leukemia Treatment Drugs Market Challenges
2.3.4 Leukemia Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Leukemia Treatment Drugs Players by Revenue
3.1.1 Global Top Leukemia Treatment Drugs Players by Revenue (2016-2021)
3.1.2 Global Leukemia Treatment Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Leukemia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Leukemia Treatment Drugs Revenue
3.4 Global Leukemia Treatment Drugs Market Concentration Ratio
3.4.1 Global Leukemia Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leukemia Treatment Drugs Revenue in 2020
3.5 Leukemia Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Leukemia Treatment Drugs Product Solution and Service
3.7 Date of Enter into Leukemia Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Leukemia Treatment Drugs Breakdown Data by Type
4.1 Global Leukemia Treatment Drugs Historic Market Size by Type (2016-2021)
4.2 Global Leukemia Treatment Drugs Forecasted Market Size by Type (2022-2027)
5 Leukemia Treatment Drugs Breakdown Data by Application
5.1 Global Leukemia Treatment Drugs Historic Market Size by Application (2016-2021)
5.2 Global Leukemia Treatment Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Leukemia Treatment Drugs Market Size (2016-2027)
6.2 North America Leukemia Treatment Drugs Market Size by Type
6.2.1 North America Leukemia Treatment Drugs Market Size by Type (2016-2021)
6.2.2 North America Leukemia Treatment Drugs Market Size by Type (2022-2027)
6.2.3 North America Leukemia Treatment Drugs Market Size by Type (2016-2027)
6.3 North America Leukemia Treatment Drugs Market Size by Application
6.3.1 North America Leukemia Treatment Drugs Market Size by Application (2016-2021)
6.3.2 North America Leukemia Treatment Drugs Market Size by Application (2022-2027)
6.3.3 North America Leukemia Treatment Drugs Market Size by Application (2016-2027)
6.4 North America Leukemia Treatment Drugs Market Size by Country
6.4.1 North America Leukemia Treatment Drugs Market Size by Country (2016-2021)
6.4.2 North America Leukemia Treatment Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Leukemia Treatment Drugs Market Size (2016-2027)
7.2 Europe Leukemia Treatment Drugs Market Size by Type
7.2.1 Europe Leukemia Treatment Drugs Market Size by Type (2016-2021)
7.2.2 Europe Leukemia Treatment Drugs Market Size by Type (2022-2027)
7.2.3 Europe Leukemia Treatment Drugs Market Size by Type (2016-2027)
7.3 Europe Leukemia Treatment Drugs Market Size by Application
7.3.1 Europe Leukemia Treatment Drugs Market Size by Application (2016-2021)
7.3.2 Europe Leukemia Treatment Drugs Market Size by Application (2022-2027)
7.3.3 Europe Leukemia Treatment Drugs Market Size by Application (2016-2027)
7.4 Europe Leukemia Treatment Drugs Market Size by Country
7.4.1 Europe Leukemia Treatment Drugs Market Size by Country (2016-2021)
7.4.2 Europe Leukemia Treatment Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Leukemia Treatment Drugs Market Size (2016-2027)
8.2 Asia-Pacific Leukemia Treatment Drugs Market Size by Type
8.2.1 Asia-Pacific Leukemia Treatment Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Leukemia Treatment Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Leukemia Treatment Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Leukemia Treatment Drugs Market Size by Application
8.3.1 Asia-Pacific Leukemia Treatment Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Leukemia Treatment Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Leukemia Treatment Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Leukemia Treatment Drugs Market Size by Region
8.4.1 Asia-Pacific Leukemia Treatment Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Leukemia Treatment Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Leukemia Treatment Drugs Market Size (2016-2027)
9.2 Latin America Leukemia Treatment Drugs Market Size by Type
9.2.1 Latin America Leukemia Treatment Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Leukemia Treatment Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Leukemia Treatment Drugs Market Size by Type (2016-2027)
9.3 Latin America Leukemia Treatment Drugs Market Size by Application
9.3.1 Latin America Leukemia Treatment Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Leukemia Treatment Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Leukemia Treatment Drugs Market Size by Application (2016-2027)
9.4 Latin America Leukemia Treatment Drugs Market Size by Country
9.4.1 Latin America Leukemia Treatment Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Leukemia Treatment Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Leukemia Treatment Drugs Market Size (2016-2027)
10.2 Middle East & Africa Leukemia Treatment Drugs Market Size by Type
10.2.1 Middle East & Africa Leukemia Treatment Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Leukemia Treatment Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Leukemia Treatment Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Leukemia Treatment Drugs Market Size by Application
10.3.1 Middle East & Africa Leukemia Treatment Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Leukemia Treatment Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Leukemia Treatment Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Leukemia Treatment Drugs Market Size by Country
10.4.1 Middle East & Africa Leukemia Treatment Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Leukemia Treatment Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Leukemia Treatment Drugs Introduction
11.1.4 GSK Revenue in Leukemia Treatment Drugs Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Leukemia Treatment Drugs Introduction
11.2.4 Pfizer Revenue in Leukemia Treatment Drugs Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Leukemia Treatment Drugs Introduction
11.3.4 Novartis AG Revenue in Leukemia Treatment Drugs Business (2016-2021)
11.3.5 Novartis AG Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Leukemia Treatment Drugs Introduction
11.4.4 Roche Revenue in Leukemia Treatment Drugs Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Celgene
11.5.1 Celgene Company Details
11.5.2 Celgene Business Overview
11.5.3 Celgene Leukemia Treatment Drugs Introduction
11.5.4 Celgene Revenue in Leukemia Treatment Drugs Business (2016-2021)
11.5.5 Celgene Recent Development
11.6 Biogen
11.6.1 Biogen Company Details
11.6.2 Biogen Business Overview
11.6.3 Biogen Leukemia Treatment Drugs Introduction
11.6.4 Biogen Revenue in Leukemia Treatment Drugs Business (2016-2021)
11.6.5 Biogen Recent Development
11.7 Genzyme Corporation
11.7.1 Genzyme Corporation Company Details
11.7.2 Genzyme Corporation Business Overview
11.7.3 Genzyme Corporation Leukemia Treatment Drugs Introduction
11.7.4 Genzyme Corporation Revenue in Leukemia Treatment Drugs Business (2016-2021)
11.7.5 Genzyme Corporation Recent Development
11.8 Eisai C.
11.8.1 Eisai C. Company Details
11.8.2 Eisai C. Business Overview
11.8.3 Eisai C. Leukemia Treatment Drugs Introduction
11.8.4 Eisai C. Revenue in Leukemia Treatment Drugs Business (2016-2021)
11.8.5 Eisai C. Recent Development
11.9 Bristol Myers Squibb Company (BMS)
11.9.1 Bristol Myers Squibb Company (BMS) Company Details
11.9.2 Bristol Myers Squibb Company (BMS) Business Overview
11.9.3 Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Introduction
11.9.4 Bristol Myers Squibb Company (BMS) Revenue in Leukemia Treatment Drugs Business (2016-2021)
11.9.5 Bristol Myers Squibb Company (BMS) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Leukemia Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Gleevec
Table 3. Key Players of Sapacitabine
Table 4. Key Players of GA101
Table 5. Key Players of Vasaroxine
Table 6. Key Players of Tosedosat
Table 7. Key Players of Revlimid
Table 8. Key Players of Bosutinib
Table 9. Global Leukemia Treatment Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Leukemia Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Leukemia Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Leukemia Treatment Drugs Market Share by Regions (2016-2021)
Table 13. Global Leukemia Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Leukemia Treatment Drugs Market Share by Regions (2022-2027)
Table 15. Leukemia Treatment Drugs Market Trends
Table 16. Leukemia Treatment Drugs Market Drivers
Table 17. Leukemia Treatment Drugs Market Challenges
Table 18. Leukemia Treatment Drugs Market Restraints
Table 19. Global Leukemia Treatment Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Leukemia Treatment Drugs Market Share by Players (2016-2021)
Table 21. Global Top Leukemia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukemia Treatment Drugs as of 2020)
Table 22. Ranking of Global Top Leukemia Treatment Drugs Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Leukemia Treatment Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Leukemia Treatment Drugs Product Solution and Service
Table 26. Date of Enter into Leukemia Treatment Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Leukemia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Leukemia Treatment Drugs Revenue Market Share by Type (2016-2021)
Table 30. Global Leukemia Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Leukemia Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Leukemia Treatment Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Leukemia Treatment Drugs Revenue Market Share by Application (2016-2021)
Table 34. Global Leukemia Treatment Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Leukemia Treatment Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Leukemia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Leukemia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Leukemia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Leukemia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Leukemia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Leukemia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Leukemia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Leukemia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Leukemia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Leukemia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Leukemia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Leukemia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Leukemia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Leukemia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Leukemia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Leukemia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Leukemia Treatment Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Leukemia Treatment Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Leukemia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Leukemia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Leukemia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Leukemia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Leukemia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Leukemia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Leukemia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Leukemia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Leukemia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Leukemia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Leukemia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Leukemia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 66. GSK Company Details
Table 67. GSK Business Overview
Table 68. GSK Leukemia Treatment Drugs Product
Table 69. GSK Revenue in Leukemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 70. GSK Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Leukemia Treatment Drugs Product
Table 74. Pfizer Revenue in Leukemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Novartis AG Company Details
Table 77. Novartis AG Business Overview
Table 78. Novartis AG Leukemia Treatment Drugs Product
Table 79. Novartis AG Revenue in Leukemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 80. Novartis AG Recent Development
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Leukemia Treatment Drugs Product
Table 84. Roche Revenue in Leukemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 85. Roche Recent Development
Table 86. Celgene Company Details
Table 87. Celgene Business Overview
Table 88. Celgene Leukemia Treatment Drugs Product
Table 89. Celgene Revenue in Leukemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 90. Celgene Recent Development
Table 91. Biogen Company Details
Table 92. Biogen Business Overview
Table 93. Biogen Leukemia Treatment Drugs Product
Table 94. Biogen Revenue in Leukemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 95. Biogen Recent Development
Table 96. Genzyme Corporation Company Details
Table 97. Genzyme Corporation Business Overview
Table 98. Genzyme Corporation Leukemia Treatment Drugs Product
Table 99. Genzyme Corporation Revenue in Leukemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 100. Genzyme Corporation Recent Development
Table 101. Eisai C. Company Details
Table 102. Eisai C. Business Overview
Table 103. Eisai C. Revenue in Leukemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 104. Eisai C. Recent Development
Table 105. Bristol Myers Squibb Company (BMS) Company Details
Table 106. Bristol Myers Squibb Company (BMS) Business Overview
Table 107. Bristol Myers Squibb Company (BMS) Leukemia Treatment Drugs Product
Table 108. Bristol Myers Squibb Company (BMS) Revenue in Leukemia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 109. Bristol Myers Squibb Company (BMS) Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Leukemia Treatment Drugs Market Share by Type: 2020 VS 2027
Figure 2. Gleevec Features
Figure 3. Sapacitabine Features
Figure 4. GA101 Features
Figure 5. Vasaroxine Features
Figure 6. Tosedosat Features
Figure 7. Revlimid Features
Figure 8. Bosutinib Features
Figure 9. Global Leukemia Treatment Drugs Market Share by Application: 2020 VS 2027
Figure 10. Hospitals Case Studies
Figure 11. Research Institutes Case Studies
Figure 12. Diagnostic Centers Case Studies
Figure 13. Others Case Studies
Figure 14. Leukemia Treatment Drugs Report Years Considered
Figure 15. Global Leukemia Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Leukemia Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Leukemia Treatment Drugs Market Share by Regions: 2020 VS 2027
Figure 18. Global Leukemia Treatment Drugs Market Share by Regions (2022-2027)
Figure 19. Global Leukemia Treatment Drugs Market Share by Players in 2020
Figure 20. Global Top Leukemia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukemia Treatment Drugs as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Leukemia Treatment Drugs Revenue in 2020
Figure 22. Global Leukemia Treatment Drugs Revenue Market Share by Type (2016-2021)
Figure 23. Global Leukemia Treatment Drugs Revenue Market Share by Type (2022-2027)
Figure 24. North America Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Leukemia Treatment Drugs Market Share by Type (2016-2027)
Figure 26. North America Leukemia Treatment Drugs Market Share by Application (2016-2027)
Figure 27. North America Leukemia Treatment Drugs Market Share by Country (2016-2027)
Figure 28. United States Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Leukemia Treatment Drugs Market Share by Type (2016-2027)
Figure 32. Europe Leukemia Treatment Drugs Market Share by Application (2016-2027)
Figure 33. Europe Leukemia Treatment Drugs Market Share by Country (2016-2027)
Figure 34. Germany Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Leukemia Treatment Drugs Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Leukemia Treatment Drugs Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Leukemia Treatment Drugs Market Share by Region (2016-2027)
Figure 44. China Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Leukemia Treatment Drugs Market Share by Type (2016-2027)
Figure 52. Latin America Leukemia Treatment Drugs Market Share by Application (2016-2027)
Figure 53. Latin America Leukemia Treatment Drugs Market Share by Country (2016-2027)
Figure 54. Mexico Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Leukemia Treatment Drugs Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Leukemia Treatment Drugs Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Leukemia Treatment Drugs Market Share by Country (2016-2027)
Figure 60. Turkey Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Leukemia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. GSK Revenue Growth Rate in Leukemia Treatment Drugs Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Leukemia Treatment Drugs Business (2016-2021)
Figure 65. Novartis AG Revenue Growth Rate in Leukemia Treatment Drugs Business (2016-2021)
Figure 66. Roche Revenue Growth Rate in Leukemia Treatment Drugs Business (2016-2021)
Figure 67. Celgene Revenue Growth Rate in Leukemia Treatment Drugs Business (2016-2021)
Figure 68. Biogen Revenue Growth Rate in Leukemia Treatment Drugs Business (2016-2021)
Figure 69. Genzyme Corporation Revenue Growth Rate in Leukemia Treatment Drugs Business (2016-2021)
Figure 70. Eisai C. Revenue Growth Rate in Leukemia Treatment Drugs Business (2016-2021)
Figure 71. Bristol Myers Squibb Company (BMS) Revenue Growth Rate in Leukemia Treatment Drugs Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の有毛細胞白血病治療市場規模・現状・予測（2021年-2027年） Hairy cell leukemia is a rare type of cancer of blood which is caused due to abnormal growth of B cells. It has been observed that out of all the leukemia’s, hairy cell leukemia accounts for about 2% and thus eventually must be treated after its prominent symptoms. The drivers for the HCL market can…- 世界の慢性骨髄性白血病治療市場規模・現状・予測（2021年-2027年） Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells of the bone marrow. Market Analysis and Insights: Global Chronic Myelogenous Leukemia Treatment Market The global Chronic Myelogenous Leukemia Treatment mark…
- 世界の慢性骨髄性白血病治療市場規模・現状・予測（2021年-2027年） Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells of the bone marrow. Market Analysis and Insights: Global Chronic Myelogenous Leukemia Treatment Market The global Chronic Myelogenous Leukemia Treatment mark…
- 世界の急性骨髄性白血病（AML）治療市場規模・現状・予測（2021年-2027年） Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90…
- 世界の急性リンパ性/リンパ芽球性白血病薬市場規模・現状・予測（2021年-2027年） Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes. Market Analysis and Insights: Global Acute Lymphocytic/Lymphoblastic Leukemia Drugs Market The global Acute Lymphocytic/Lymphoblastic Leukemia…